We make healthy possible

COVID-19 Response and Update

160+ Million Scripts
Filled in the U.S.

with Amneal medicines in 2024 (Source: IQVIA, National Prescription Audit, Dec 2024)

Oncology

Innovative cancer & supportive care therapies.

Parkinson’s Community

We help patients & care partners navigate Parkinson’s disease.

Saving Lives

Doing our part to increase access to Naloxone Nasal Spray.

Leader in Accessible Medicines

We develop first-to-file and first-to-market complex medicines

160+ Million Scripts Filled in the U.S.
with Amneal medicines in 2024 (Source: IQVIA, National Prescription Audit, Dec 2024)

Oncology
Innovative cancer & supportive care therapies.

Parkinson’s Community
We help patients & care partners navigate Parkinson’s disease.

Saving Lives
Doing our part to increase access to Naloxone Nasal Spray.

Leader in Accessible Medicines
We develop first-to-file and first-to-market complex medicines

We make healthy possible^®

Product Updates

See Warning. Do not take Brekiya autoinjector with strong CYP3A4 inhibitors including protease inhibitors and macrolide antibiotics. For full prescribing information, including BOXED WARNING, see our product labeling at Brekiya.com(Opens in a new window).

Product Labeling(Opens in a new window) Product Website(Opens in a new window) Press Release(Opens in a new window)

The most common adverse reactions are nausea and anxiety. For full prescribing information, see our product labeling.

Product Labeling(Opens in a new window) Product Website(Opens in a new window) Press Release(Opens in a new window)

Our Products

Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.

Generics Products Specialty Products Biosciences Products (Opens in a new tab) Expanded Access Policy Important Label Information for Temozolomide Capsules, USP, 250 mg(Opens in a new tab)